World Journal of Clinical Cases - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	McCormack MD, Wahedna NA, Aldulaimi D, Hawker P. Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease. World J Clin Cases 2023; 11(12): 2621-2630 [PMID: 37214562 DOI: 10.12998/wjcc.v11.i12.2621]
URL:	https://www.wjgnet.com/2307-8960/full/v11/i12/2621.htm

(139) (159) (0) (0) (0) (19) (1) (6572) (21)

Number	Citing Articles
1	Michael Colwill, Samantha Baillie, Richard Pollok, Andrew Poullis. Using clinical cases to guide healthcare. World Journal of Clinical Cases 2024; 12(9): 1555-1559 doi: 10.12998/wjcc.v12.i9.1555 Abstract(1090) \| Core Tip(848) \| Full Article(HTML)(1968) \| Full Article (PDF)-538K(182) \| Full Article with Cover (PDF)-957K(138) \| Full Article (XML)-42K(133) \| Audio-409K(18) \| Peer-Review Report-170K(130) \| Answering Reviewers-81K(139) \| Times Cited (1) \| Total Visits (2979) \| Open
2	Kate Lee, Violet Tu, Adam Faye. Optimal Management of Refractory Crohn’s Disease: Current Landscape and Future Direction. Clinical and Experimental Gastroenterology 2024; doi: 10.2147/CEG.S359376
3	Cathrine Dawn Büttner Elgaard, Trine Bay Laurberg, Jørgen Agnholt, Anne Gitte Loft, Kasper Fjellhaugen Hjuler. Advanced Combination Therapy with Tofacitinib and Biologic Agents for Psoriasis and Psoriatic Arthritis: A Case Series. Case Reports in Dermatology 2025; 17(1) doi: 10.1159/000547724
4	Aurora Zanghì, Paola Sofia Di Filippo, Claudia Rutigliano, Carlo Avolio, Emanuele D’Amico. Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1634477
5	Puo-Hsien Le, Chien-Ming Chen, Chia-Jung Kuo, Ming-Yao Su, Cheng-Tang Chiu, Yung-Kuan Tsou. Dual Biologic Therapy for Refractory Crohn's Disease With Perforation in a Patient Declining Surgical Intervention. ACG Case Reports Journal 2023; 10(11) doi: 10.14309/crj.0000000000001203
6	Mohammed Khalil Jnyah, Imane El Mezouar, Nessrine Akasbi, Taoufik Harzy. Pharmacological management of spondyloarthritis associated with inflammatory bowel disease: a systematic review of efficacy, safety, and emerging therapies. BMC Rheumatology 2025; 9(1) doi: 10.1186/s41927-025-00559-y
7	Haiyan Lu, Xiangdang Hu, Yan Chen, Jie He. Colorectal cancer in ulcerative colitis: unraveling mechanisms and advancing surveillance and chemoprevention. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1793470
8	Andrea Papait, Anna Cargnoni, Franco Scaldaferri, Loris Lopetuso, Antonietta Rosa Silini, Ornella Parolini. Inflammatory Bowel Disease: Mechanisms and Therapeutic Advances. MedComm 2026; 7(9) doi: 10.1002/mco2.70914
9	Javier P Gisbert, María Chaparro. Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive review. Journal of Crohn's and Colitis 2025; 19(9) doi: 10.1093/ecco-jcc/jjaf161
10	Jana G Hashash, Jimmy K Limdi, Jason M Shapiro, Samir A Shah. Medical management of inflammatory bowel diseases. BMJ 2025; 391 doi: 10.1136/bmj-2025-079050
11	So Jung Han, Jae Hee Cheon. Advanced Combination Therapy in Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2026; 86(2) doi: 10.4166/kjg.2025.142
12	Andreia C Guimarães, Rocio Ferreiro-Iglesias, Cristina Calviño-Suarez, Iria Baston-Rey, Manuel Barreiro-de Acosta. Dual biologic therapy in patient with refractory ulcerative colitis and comorbidities: A case report. World Journal of Gastroenterology 2025; 31(47): 113381 doi: 10.3748/wjg.v31.i47.113381 Abstract(128) \| Core Tip(105) \| Full Article(HTML)(626) \| Full Article (PDF)-589K(108) \| Full Article with Cover (PDF)-844K(109) \| Full Article (XML)-39K(80) \| Audio-845K(12) \| Peer-Review Report-463K(37) \| Answering Reviewers-82K(46) \| Times Cited (0) \| Total Visits (1007) \| Open
13	F. Carvajal, P. Núñez, R. Quera, G. Pizarro, L. Flores. Advanced combination therapy: Janus kinase inhibitors and TNF inhibitors in the treatment of patients with inflammatory bowel disease. Revista de Gastroenterología de México (English Edition) 2026; 91(1) doi: 10.1016/j.rgmxen.2025.06.002
14	Filiz Akyuz, Oguz Kagan Bakkaloglu, Nalan Gulsen Unal, Ismail Hakki Kalkan, Mehmet Arhan, Ibrahim Hatemi, Taylan Kav, Murat Toruner, Hale Akpinar, Ahmet Tezel, Aykut Ferhat Celik. Management of Refractory and Difficult‐To‐Treat Inflammatory Bowel Disease: An Expert Opinion Review. JCC Plus 2026; 1(5) doi: 10.1002/jcc5.70082
15	F. Carvajal, P. Núñez, R. Quera, G. Pizarro, L. Flores. Terapia combinada avanzada: inhibidores janus kinasas y anti-TNF en el tratamiento de pacientes con enfermedad inflamatoria intestinal. Revista de Gastroenterología de México 2026; 91(1) doi: 10.1016/j.rgmx.2025.06.015
16	Fadi Hassan, Helana Jeries, Rula Daood, Mohammad Naffaa. Beyond Monotherapy: Exploring the Efficacy and Safety of Dual Biologic Strategies in Rheumatic Diseases. Biologics: Targets and Therapy 2025; doi: 10.2147/BTT.S565137
17	Arghya Samanta, Anshu Srivastava. Biologics in the management of pediatric inflammatory bowel disease: When and what to choose. World Journal of Clinical Pediatrics 2025; 14(1): 100938 doi: 10.5409/wjcp.v14.i1.100938 Abstract(583) \| Core Tip(604) \| Full Article(HTML)(6700) \| Full Article (PDF)-1397K(726) \| Full Article with Cover (PDF)-4150K(310) \| Full Article (XML)-427K(150) \| Audio-2330K(23) \| Peer-Review Report-222K(122) \| Answering Reviewers-63K(117) \| Times Cited (4) \| Total Visits (9278) \| Open
18	Christina M. Ray, Remo Panaccione, Christopher Ma. A practical guide to combination advanced therapy in inflammatory bowel disease. Current Opinion in Gastroenterology 2024; 40(4) doi: 10.1097/MOG.0000000000001033
19	Mohamed Mahmoud Hafez, Ibrahim Halil Bahcecioglu, Mehmet Yalniz, Karim Abdelwahab Kouta, Ahmed Tawheed. Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines. World Journal of Methodology 2025; 15(4): 107643 doi: 10.5662/wjm.v15.i4.107643 Abstract(372) \| Core Tip(366) \| Full Article(HTML)(6760) \| Full Article (PDF)-480K(494) \| Full Article with Cover (PDF)-810K(167) \| Full Article (XML)-130K(82) \| Audio-186K(26) \| Peer-Review Report-329K(70) \| Answering Reviewers-307K(87) \| Times Cited (3) \| Total Visits (7848) \| Open
20	Jessica R Allegretti, Liliana G Bordeianou, Oriana M Damas, Samuel Eisenstein, Ruby Greywoode, Phillip Minar, Siddharth Singh, Sabrina Harmon, Eugene Lisansky, Myisha Malone-King, Nicole S Litwin, Alandra Weaver, Caren A Heller, Alan C Moss, Jeremy Adler. Challenges in IBD Research 2024: Pragmatic Clinical Research. Inflammatory Bowel Diseases 2024; 30(Supplement_2) doi: 10.1093/ibd/izae083
21	Giammarco Mocci, Antonio Tursi, Francesca Maria Onidi, Paolo Usai-Satta, Giovanni Mario Pes, Maria Pina Dore. Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms. Journal of Clinical Medicine 2024; 13(5) doi: 10.3390/jcm13051519
22	Hiu C. L. Sin, Craig Haifer. Faecal transplantation: the good, the bad and the ugly. Internal Medicine Journal 2025; 55(1) doi: 10.1111/imj.16559